Findings showed fenebrutinib significantly reduced relapses vs teriflunomide in RMS and was noninferior to ocrelizumab in slowing disability progression in PPMS. Topline data were announced from two ...
A phase 3 trial evaluating a nebulized clofazimine inhalation suspension (MNKD-101) for the treatment of refractory nontuberculous mycobacterial (NTM) ...
(HealthDay News) — Long-term melatonin use for treatment of insomnia is associated with a higher risk for incident heart failure and all-cause mortality, according to a study to be presented at the ...
(HealthDay News) — A peanut patch treatment ( Viaskin Peanut Patch; [VP250]) continues to help toddlers safely build tolerance to peanuts over 3 years, according to a study presented at the annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback